Search Tag: Hologic

2016 28 Apr

Breast tomosynthesis exams, combined with conventional mammography, can help reduce recall rates, and increase invasive cancer detection in women with both dense and non-dense breasts, according to research published in the Journal of the American Medical Association. These key benefits could lower the costs associated with needless follow-up...Read more

2016 27 Apr

Reducing Recall Rate for Breast Cancer Screening Stands to Decrease Healthcare Costs and Increase Quality of Care for Women Hologic, Inc. has announced that study results published today in a research letter in  JAMA  conclude that breast tomosynthesis (Hologic's Genius™ 3D MAMMOGRAPHY™) exams reduce recall rates, and increase invasive cancer detection...Read more

2016 21 Apr

New System Pairs 360-Degree Breast Access with Exceptional 2D/3D™ Biopsy Imaging Hologic, Inc. has announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of the Affirm™ prone biopsy system, the first dedicated prone biopsy system to offer both 2D and 3D™ imaging-guided breast biopsies. "At Hologic, we challenge...Read more

2016 02 Apr

Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued  November 23, 2010 , and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes.  This conversion right is subject to the terms...Read more

2016 01 Apr

Hologic, Inc. has announced that the Company plans to release its financial results for the second quarter of fiscal 2016 on Wednesday, April 27, 2016, after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.  Interested participants may listen to the call by dialing 888-455-2271...Read more

2016 04 Mar

The CE-Marked Affirm™ Prone Biopsy System Provides Enhanced 2D/3D™ Biopsy Imaging and Faster, Easier Access to the Breast [i] Hologic, Inc. has announced  the European launch of the CE-marked Affirm™ prone biopsy system — the first dedicated prone biopsy system capable of both 2D and 3D™ imaging-guided breast biopsies. The new product is...Read more

2016 02 Mar

Hologic, Inc. (Nasdaq: HOLX) has announced that  Christopher J. Coughlin  has joined the Company's Board of Directors.  Mr. Coughlin was elected to the Board at the Company's 2016 Annual Meeting of Stockholders, along with nine existing Directors who were re-elected. Mr. Coughlin, who in December was named "Director of the Year" by the National Association...Read more

2016 19 Feb

Hologic Inc. has announced that a new longitudinal study  published online in advance of print in  JAMA Oncology  reports that women screened for breast cancer over multiple years using Hologic's Genius 3D MAMMOGRAPHY™ exams benefited from a significant drop in costly and stressful recalls. 1 The findings published in  JAMA Oncology  provide longitudinal...Read more

2016 15 Feb

Several locations have started high volume screening with Hologic 3D Mammography™ in Europe. A large scale adoption is ongoing in the USA with some locations past their third screening round with Hologic 3D Mammography. Results from the use of this technology in screening are concordant and very positive around an increase in invasive cancer detection...Read more

2016 15 Feb

Hologic is offering a series of 90-minute educational sessions for radiologists throughout the ECR Congress. Prior to the hands-on, a brief lecture will be provided by a radiologist pioneer in the clinical use of 3D Mammography™, who will present an overview of the technology and reading principles of tomosynthesis.  This program is intended for radiologists...Read more

2016 15 Feb

Hologic is offering a series of 45-minute educational sessions for radiologists. A brief lecture will provide an overview of the clinical experiences with vacuum breast biopsies guided by 3D Imaging, prior to a demonstration of a phantom procedure using live imaging supervised by radiation protection services.  This program is intended for radiologists...Read more

2016 15 Feb

Hologic is offering a series of 45-minutes educational sessions for radiologists. A brief lecture will provide an overview of the clinical experiences of imaging and new quantification applications of DXA.  This program is intended for radiologists interested in learning more about new application based on the Hologic DXA technology. Date...Read more

2016 03 Feb

Hologic, Inc. has announced that the Company will present at these upcoming investor conferences: The LEERINK Partners 5 th  Annual Global Healthcare Conference in  New York, NY  on  Wednesday, February 10  at  3:05 pm Eastern Time  (ET). The RBC Capital Markets 2016 Global Healthcare Conference in  New York, NY  on  Tuesday, FebrRead more

2016 05 Jan

Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes.  This conversion right is subject to the terms of...Read more

2016 04 Jan

Hologic, Inc. has announced that the Company plans to release its financial results for the first quarter of fiscal 2016 on  Wednesday, January 27, 2016 , after the market closes.  In conjunction with the release, management will host a conference call that day at  4:30 p.m. Eastern Time . Interested participants may listen to the call by dialing...Read more

2015 22 Dec

Hologic, Inc. has expressed support for new federal measures that preserve access to mammography for breast cancer screening and increase incentives for biomedical research and development.  These measures were recently passed with bipartisan Congressional support and signed into law by the President. Essential components of the Protect Access to...Read more

2015 21 Dec

Hologic, Inc. has announced that the Company will present at the 34th Annual J.P. Morgan Healthcare Conference in  San Francisco  on  January 12, 2016  at  2 p.m. Pacific Time . The presentation will be webcast live and may be accessed through a link on the investors section of Hologic's website at  http://investors.hologic.com .  The webcast will...Read more

2015 16 Dec

-- The CE-marked Aptima® Mycoplasma genitalium Assay on the Panther® System Identifies a Prevalent, Often Misdiagnosed Sexually Transmitted Infection --   Hologic, Inc. has announced the European launch of the CE-marked Aptima Mycoplasma genitalium assay, adding to the growing menu of molecular tests available on the fully automated Panther system....Read more

2015 10 Dec

-- Aptima® HBV Quant Assay Joins Tests for HIV-1 and HCV on the Fully Automated Panther Instrument -- Hologic, Inc. has earned CE-IVD certification for its Aptima HBV Quant assay on the fully automated Panther® instrument, the Company has announced.   This assay expands the European virology menu available on the Panther system, which previously...Read more

2015 07 Dec

A high-profile conference for Boston-area women will host Marlborough-based Hologic and its 40-foot 3D MAMMOGRAPHY™ bus, a hands-on display of the latest innovation in breast cancer screening.   Hologic’s 3D MAMMOGRAPHY™ bus is a walk-through tour and information center for women to learn about a new kind of mammogram, which clinical studies have...Read more

2015 12 Nov

Co-testing could prevent more cases of invasive cervical cancer and cost the health care system less money over time, study shows Researchers presented a new clinical-economic modeling analysis this week showing that screening for cervical cancer with Pap+HPV Together™ (co-testing) using the Aptima® HPV assay (an mRNA-based HPV test) and the...Read more

2015 30 Sep

Chenoweth to Serve as Spokeswoman for National Campaign to Increase Insurance Coverage of Hologic's Genius™ 3D Mammography™ Exam -- Hologic, Inc. (Nasdaq: HOLX) announced that award-winning actress and singer  Kristin Chenoweth  will join  Steve MacMillan , the Company's Chairman, President and Chief Executive Officer, to ring the Nasdaq Opening...Read more

2015 29 Sep

Mammography providers say Hologic stands out for technology innovation, high image quality, and C-View™ dose-reduction technology Hologic, Inc. (NASDAQ: HOLX) announced that U.S. mammography providers gave Hologic and Hologic's Genius™ 3D Mammography™ exams top scores in a new study by KLAS Research, Women's Imaging 2015. Are New Technologies Delivering...Read more

2015 16 Jul

Hologic, Inc. (NASDAQ: HOLX) has commented on an important cervical cancer screening studyipublished on-line this week in  Cancer Cytopathology , a peer-reviewed journal of the American Cancer Society. The study, by researchers at Quest Diagnostics and the University of Pittsburgh Medical Center, supports current consensus guidelinesii for cervical...Read more

2015 17 Jun

BEDFORD, Mass. , / PRNewswire / -- Hologic, Inc. (NASDAQ: HOLX) announced that  David LaVance  has resigned as Chairman of the Company's Board of Directors, and notified the Board that he will not stand for re-election at the 2016 Annual Meeting of Stockholders. Steve MacMillan , Hologic's President and Chief Executive Officer, has been appointed...Read more

2015 15 Jun

BEDFORD, Mass. ,/ PRNewswire / --   Hologic, Inc. (NASDAQ: HOLX) announced that award-winning actress and singer  Kristin Chenoweth  will serve as spokesperson for a national campaign to generate awareness of Hologic's Genius 3D Mammography exam, a more accurate mammogram that has been clinically proven to reduce callbacks by up to 40 percent and...Read more

2015 29 May

Initial Proceeds from New $1.5 Billion Term Loan and $1 Billion Revolving Credit Line Used to Refinance Senior Secured Debt PRNewswire / -- Hologic, Inc. (NASDAQ: HOLX) announced that the Company has entered into a new, five-year secured credit agreement consisting of a  $1.5 billion  senior Term Loan and a  $1 billion  revolving credit facility....Read more

2015 07 May

BEDFORD, Mass. ,  May 7, 2015 / PRNewswire / -- Hologic, Inc. (NASDAQ: HOLX) announced today that the Company will present at two upcoming investor conferences in May: The Bank of America Merrill Lynch 2015 Healthcare Conference in  Las Vegas  on  Tuesday, May 12  at  1:40 pm Pacific Time  (PT). The UBS Global Healthcare Conference in  New York...Read more

2015 29 Apr

- Revenues of $655.5 Million Grow 4.9% on a Reported Basis, 7.2% in Constant Currency - - Company Records GAAP EPS of $0.17, Non-GAAP EPS of $0.41 - - Company Raises Full-Year Revenue and Earnings Guidance - BEDFORD, Mass. , / PRNewswire / -- Hologic, Inc. (NASDAQ: HOLX) announced today the Company's financial results for the second...Read more

2015 16 Apr

BEDFORD, Mass. , / PRNewswire / -- Hologic, Inc. (NASDAQ: HOLX) today commented on an important cervical cancer screening studyi published on-line this week in  Cancer Cytopathology , a peer-reviewed journal of the American Cancer Society. The study, by researchers at Quest Diagnostics and the University of Pittsburgh Medical Center, supports current...Read more